These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 12924569)

  • 1. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
    Perkins R; Fang H; Tong W; Welsh WJ
    Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic QSAR techniques: applications in drug design and toxicology.
    Mekenyan O
    Curr Pharm Des; 2002; 8(17):1605-21. PubMed ID: 12052203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the international workshops on quantitative structure-activity relationships (QSARs) in environmental toxicology.
    Kaiser KL
    SAR QSAR Environ Res; 2007; 18(1-2):3-20. PubMed ID: 17365955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the nature, evolution and future of quantitative structure-activity relationships (QSAR) in toxicology.
    Veith GD
    SAR QSAR Environ Res; 2004; 15(5-6):323-30. PubMed ID: 15669692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design.
    Roy K; Mitra I
    Comb Chem High Throughput Screen; 2011 Jul; 14(6):450-74. PubMed ID: 21521150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship approaches and applications.
    Tong W; Welsh WJ; Shi L; Fang H; Perkins R
    Environ Toxicol Chem; 2003 Aug; 22(8):1680-95. PubMed ID: 12924570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of prediction confidence and domain extrapolation of two structure-activity relationship models for predicting estrogen receptor binding activity.
    Tong W; Xie Q; Hong H; Shi L; Fang H; Perkins R
    Environ Health Perspect; 2004 Aug; 112(12):1249-54. PubMed ID: 15345371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-QSAR in drug design--a review.
    Verma J; Khedkar VM; Coutinho EC
    Curr Top Med Chem; 2010; 10(1):95-115. PubMed ID: 19929826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR in the pharmaceutical research setting: QSAR models for broad, large problems.
    Sprous DG; Palmer RK; Swanson JT; Lawless M
    Curr Top Med Chem; 2010; 10(6):619-37. PubMed ID: 20337590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Study of In Vitro GPCR Assays by QSAR Modeling.
    Mansouri K; Judson RS
    Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
    Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
    Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4D- quantitative structure-activity relationship modeling: making a comeback.
    Fourches D; Ash J
    Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
    [No Abstract]   [Full Text] [Related]  

  • 14. QSAR modeling of cumulative environmental end-points for the prioritization of hazardous chemicals.
    Gramatica P; Papa E; Sangion A
    Environ Sci Process Impacts; 2018 Jan; 20(1):38-47. PubMed ID: 29226926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
    González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
    Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on principles, theory and practices of 2D-QSAR.
    Roy K; Das RN
    Curr Drug Metab; 2014; 15(4):346-79. PubMed ID: 25204823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in multidimensional QSAR (4D-6D): a critical review.
    Damale MG; Harke SN; Kalam Khan FA; Shinde DB; Sangshetti JN
    Mini Rev Med Chem; 2014 Jan; 14(1):35-55. PubMed ID: 24195665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of QSARs and VFARs to the rapid risk assessment process at US EPA.
    Moudgal CJ; Young D; Nichols T; Martin T; Harten P; Venkatapathy R; Stelma G; Siddhanti S; Baier-Anderson C; Wolfe M
    SAR QSAR Environ Res; 2008; 19(5-6):579-87. PubMed ID: 18853303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring QSARs with Extended Topochemical Atom (ETA) indices for modeling chemical and drug toxicity.
    Roy K; Ghosh G
    Curr Pharm Des; 2010; 16(24):2625-39. PubMed ID: 20642426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.